Targeting RIP3-mediated necroptosis for chemosensitization
Ended Cooperative Agreement Awarded Last action
- Award ID
- R21CA193633
- Recipient
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $512,506
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $232,594 | |
| Amendment | -$235,578 | |
| Amendment | $23,708 | |
| Amendment | $213,367 | |
| Original award | $278,415 |
Quick answers
Who received award R21CA193633?
R21CA193633 was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by National Cancer Institute (National Institutes of Health) on April 1, 2016.
How much is award R21CA193633 worth?
$512,506 has been obligated on R21CA193633.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award